37 related articles for article (PubMed ID: 2459613)
21. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
Atassi MZ; Oshima M; Deitiker P
Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
[TBL] [Abstract][Full Text] [Related]
22. Humoral pathogenesis of myasthenia gravis.
Drachman DB; de Silva S; Ramsay D; Pestronk A
Ann N Y Acad Sci; 1987; 505():90-105. PubMed ID: 2446560
[No Abstract] [Full Text] [Related]
23. Antigenic structure of the muscle nicotinic acetylcholine receptor.
Tzartos SJ; Cung MT; Mamalaki A; Marraud M; Papanastasiou D; Sakarellos C; Sakarellos-Daitsiotis M; Tsantili P
Ann Med Interne (Paris); 1996; 147(6):442-6. PubMed ID: 9092347
[No Abstract] [Full Text] [Related]
24. Myasthenia gravis: nicotinic acetylcholine receptors as targets for autoimmune attack.
Newsom-Davis J; Harcourt G; Beeson D
Biochem Soc Trans; 1989 Aug; 17(4):635-7. PubMed ID: 2670631
[No Abstract] [Full Text] [Related]
25. Molecular mimicry and microorganisms: a role in the pathogenesis of myasthenia gravis?
Dieperink ME; Stefansson K
Curr Top Microbiol Immunol; 1989; 145():57-65. PubMed ID: 2478337
[No Abstract] [Full Text] [Related]
26. Helper T cells in antibody-mediated, organ-specific autoimmunity.
Elson CJ; Barker RN
Curr Opin Immunol; 2000 Dec; 12(6):664-9. PubMed ID: 11102770
[TBL] [Abstract][Full Text] [Related]
27. T cell receptor gene regulation of experimental autoimmune myasthenia gravis.
Wu B; Shenoy M; Christadoss P
Adv Neuroimmunol; 1994; 4(4):433-45. PubMed ID: 7536604
[No Abstract] [Full Text] [Related]
28. Examination of characteristics that may distinguish disease-causing from benign AChR-reactive antibodies in experimental autoimmune myasthenia gravis.
Krolick KA; Zoda TE; Thompson PA
Adv Neuroimmunol; 1994; 4(4):475-93. PubMed ID: 7719619
[TBL] [Abstract][Full Text] [Related]
29. The role of major histocompatibility complex genes in myasthenia gravis and experimental autoimmune myasthenia gravis pathogenesis.
Kaul R; Shenoy M; Christadoss P
Adv Neuroimmunol; 1994; 4(4):387-402. PubMed ID: 7536602
[No Abstract] [Full Text] [Related]
30. [Immunologic tests: Anti-acetylcholine receptor antibody (non-blocking type and blocking type antibodies)].
Ohta M; Ohta K
Nihon Rinsho; 2005 Jul; 63 Suppl 7():585-8. PubMed ID: 16111339
[No Abstract] [Full Text] [Related]
31. The thymus in myasthenia gravis.
Wekerle H
Ann N Y Acad Sci; 1993 Jun; 681():47-55. PubMed ID: 8357188
[No Abstract] [Full Text] [Related]
32. Molecular and antigenic structure of nicotinic acetylcholine receptors.
Lindstrom J; Peng X; Kuryatov A; Lee E; Anand R; Gerzanich V; Wang F; Wells G; Nelson M
Ann N Y Acad Sci; 1998 May; 841():71-86. PubMed ID: 9668222
[No Abstract] [Full Text] [Related]
33. Anti-nicotinic receptor autoimmunity in myasthenia gravis. Establishment of specific T-helper cell lines and identification of sensitizing epitopes on the alpha-subunit.
Hohlfeld R; Toyka K; Heininger K; Tzartos SJ; Walgrave SL; Protti P; Conti-Tronconi BM
Monogr Allergy; 1988; 25():50-67. PubMed ID: 2459613
[No Abstract] [Full Text] [Related]
34. Molecular anatomy of an autoantigen: T and B epitopes on the nicotinic acetylcholine receptor in myasthenia gravis.
Manfredi AA; Protti MP; Bellone M; Moiola L; Conti-Tronconi BM
J Lab Clin Med; 1992 Jul; 120(1):13-21. PubMed ID: 1377215
[No Abstract] [Full Text] [Related]
35. Myasthenia gravis: recognition of a human autoantigen at the molecular level.
Protti MP; Manfredi AA; Horton RM; Bellone M; Conti-Tronconi BM
Immunol Today; 1993 Jul; 14(7):363-8. PubMed ID: 8363727
[TBL] [Abstract][Full Text] [Related]
36. Autoimmune diseases involving nicotinic receptors.
Lindstrom J
J Neurobiol; 2002 Dec; 53(4):656-65. PubMed ID: 12436428
[TBL] [Abstract][Full Text] [Related]
37. Myasthenia gravis studied by monoclonal antibodies to the acetylcholine receptor.
Tzartos SJ
In Vivo; 1988; 2(1):105-10. PubMed ID: 2979808
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
